Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer.

Jungles, Kassidy M; Holcomb, Erin A; Pearson, Ashley N; Jungles, Kalli R; Bishop, Caroline R; Pierce, Lori J; Green, Michael D; Speers, Corey W

Jungles, Kassidy M; Holcomb, Erin A; Pearson, Ashley N; Jungles, Kalli R; Bishop, Caroline R; Pierce, Lori J; Green, Michael D; Speers, Corey W.

Afiliação

Jungles KM; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States.
Holcomb EA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States.
Pearson AN; Department of Pharmacology, University of Michigan, Ann Arbor, MI, United States.
Jungles KR; Graduate Program in Immunology, University of Michigan Medical School, Ann Arbor, MI, United States.
Bishop CR; Graduate Program in Immunology, University of Michigan Medical School, Ann Arbor, MI, United States.
Pierce LJ; Department of Biology, Saint Mary's College, Notre Dame, IN, United States.
Green MD; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States.
Speers CW; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States.

Front Oncol ; 12: 1022542, 2022.

Article em En | MEDLINE | ID: mdl-36387071

Palavras-chave

breast cancer; immune checkpoint inhibitors (ICI); immunotherapy; radiation biology; radiotherapy; tumor immunology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google